Sanofi stock toppled early Thursday despite beating expectations for blockbuster drug Dupixent. Total sales and earnings fell short.

The post Sanofi’s Biggest Drug Shined. But The Rest Of Its Business Didn’t. appeared first on Investor’s Business Daily.